Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell LymphomaXinhua Wang, Mingzhi Zhang, Lei Zhang et al.|JAMA Oncology|2022Cited by 61
Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patientsZhi‐Yuan Zhou, Mingzhi Zhang, Xiang Li et al.|Annals of Hematology|2014Cited by 52
The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus <scp>CHOP</scp> in patients with newly diagnosed peripheral T‐cell lymphoma with analysis of biomarkersLing Li, Mingzhi Zhang, Jingjing Wu et al.|British Journal of Haematology|2017Cited by 35
Inhibition of RANKL-induced osteoclastogenesis through the suppression of the ERK signaling pathway by astragaloside IV and attenuation of titanium-particle-induced osteolysisMingjun Li, Mingzhi Zhang, Wengang Wang et al.|International Journal of Molecular Medicine|2015Cited by 34
Recurrent mutations in epigenetic modifiers and the PI3K/AKT/mTOR pathway in subcutaneous panniculitis‐like T‐cell lymphomaZhaoming Li, Mingzhi Zhang, Lisha Lu et al.|British Journal of Haematology|2017Cited by 32